Finanzdaten der Biogen Inc-Aktie (BIIB)
*Alle Zahlen in Millionen
| Enddatum des Zeitraums | 2026-09-30 | 2026-06-30 | 2026-03-31 | 2025-12-31 | 2025-09-30 |
|---|---|---|---|---|---|
| Periodenlänge | 3 Monate | 3 Monate | 3 Monate | 3 Monate | 3 Monate |
| Revenues | 2.49%2,804.10 | 2,736.00 | 2,477.80 | 2,279.40 | 2,534.70 |
| Cost Of Revenue | 3.67%748.40 | 776.90 | 661.00 | 495.50 | 674.40 |
5.96%752.00 | 709.70 | 607.30 | - | - | |
| Selling, General, and Administrative | 5.96%752.00 | 709.70 | 607.30 | - | - |
| Interest Income/Expense | 6.32%87.50 | 82.30 | 67.60 | 67.50 | 67.40 |
| Costs And Expenses | 8.05%2,813.10 | 2,603.60 | 2,100.10 | 2,335.40 | 1,977.40 |
| Income/Loss From Continuing Operations Before Tax | 106.80%-9.00 | 132.40 | 377.70 | -56.00 | 557.30 |
| Income Tax Expense/Benefit, Deferred | 547.46%123.50 | -27.60 | 23.60 | 166.90 | 253.80 |
| Income Tax Expense/Benefit | 66.76%11.60 | 34.90 | 58.20 | -7.10 | 90.80 |
121.13%-20.60 | 97.50 | 319.50 | -48.90 | 466.50 | |
| Attributable To Parent | 121.13%-20.60 | 97.50 | 319.50 | -48.90 | 466.50 |
| Basic Average Shares | 0.07%147.80 | 147.70 | 147.20 | 0.10 | 146.60 |
| Diluted Average Shares | 0.61%147.80 | 148.70 | 148.40 | 0.30 | 147.10 |
| Basic Earnings Per Share | 121.21%-0.14 | 0.66 | 2.17 | -0.33 | 3.18 |
| Diluted Earnings Per Share | 121.21%-0.14 | 0.66 | 2.15 | -0.35 | 3.17 |